Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

2021-8-18 16:00

Press Release: Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. origin »

Molecule (MOL) на Currencies.ru

$ 0.0001007 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 0.00 %
Cегодня L: $0.0001007 - H: $0.0001007
Капитализация $1.287m Rank 99999
Доступно / Всего 12.782b MOL

biopharma research ip-to-nft novel molecule vitadao longevity

Источник: bitcoinist.com

biopharma research → Результатов: 3


Molecule Partners with VitaDAO and Nevermined Creating First-Ever Biopharma IP-to-NFT Transfer for Longevity Research

Press Release: Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen.

2021-8-18 16:00


Фото:

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

18th August 2021, Basel, Switzerland — For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace Molecule, and VitaDAO, a decentralized collective (DAO) funding longevity research, and the University of Copenhagen. This innovationRead More

2021-8-18 16:00


Партнеры Currencies.ru



Реклама на Currencies.ru

Самое свежее на Currencies.ru